Irritable bowel syndrome. Irritable bowel syndrome
Conditions
Interventions
Intervention 1: Intervention group: 30 patients fill out the questionnaire related to the quality of life of irritable bowel syndrome 2 weeks before starting to take rifaximin tablets and record the s
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Normal body mass index (18-25) Absence of any organic intestinal disease (diagnosis based on colonoscopy in the last 5 years) and absence of any intestinal infection (diagnosis based on stool culture) Absence of any major intestinal surgery Not taking laxatives or antidiarrheal drugs regularly Lack of medical history of gastrointestinal and colorectal diseases and absorption Lack of regular use of antibiotics and corticosteroids and immunosuppressive drugs Not taking drugs that increase bleeding from intestinal mucus such as aspirin, warfarin Absence of severe mental and behavioral disorder Not being pregnant or breastfeeding, being an athlete or being hospitalized Not taking non-steroidal anti-inflammatory drugs Absence of breast cancer in the person herself or first degree relatives
Exclusion criteria
Exclusion criteria: Taking rifaximin tablets from one year before entering the study and changing the diet during the study Failure to continue the study due to drug side effects Reluctance to cooperate Pregnancy during study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Two weeks before and two weeks after the intervention. Method of measurement: Specific quality of life questionnaire for patients with irritable bowel syndrome (IBS_QOL).;Clinical symptoms. Timepoint: Two weeks before and two weeks after the intervention. Method of measurement: Clinical interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYasin Aziminezhad
Arak University of Medical Sciences
Outcome results
None listed